NFκB in the development of endothelial activation and damage in uremia: an in vitro approach.
Impaired hemostasis coexists with accelerated atherosclerosis in patients with chronic kidney disease (CKD). The elevated frequency of atherothrombotic events has been associated with endothelial dysfunction. The relative contribution of the uremic state and the impact of the renal replacement thera...
Guardado en:
Autores principales: | Carolina Caballo, Marta Palomo, Aleix Cases, Ana M Galán, Patricia Molina, Manel Vera, Xavier Bosch, Gines Escolar, Maribel Diaz-Ricart |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3282c02b99384f9b8007bcfe2bfa9e6b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Endothelial-specific inhibition of NF-κB enhances functional haematopoiesis
por: Michael G. Poulos, et al.
Publicado: (2016) -
Omega-3 Polyunsaturated Fatty Acid Attenuates Uremia-Induced Brain Damage in Mice
por: Eun-Ji Kim, et al.
Publicado: (2021) -
Volatile organic compounds in uremia.
por: Nikolaos Pagonas, et al.
Publicado: (2012) -
Dauricine Attenuates Vascular Endothelial Inflammation Through Inhibiting NF-κB Pathway
por: Ji Hu, et al.
Publicado: (2021) -
Genomic locus proteomic screening identifies the NF-κB signaling pathway components NFκB1 and IKBKG as transcriptional regulators of Ripk3 in endothelial cells.
por: Siqi Gao, et al.
Publicado: (2021)